UBS Group’s LivaNova LIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-343,900
Closed -$17.5M 10965
2022
Q3
$17.5M Buy
343,900
+5,500
+2% +$326K 0.01% 1374
2022
Q2
$21.1M Buy
+338,400
New +$24M 0.01% 1271

Other funds holding LIVN

UBS Group's LIVN Position: Q1 2026 in Review

UBS Group reduced its LivaNova (LIVN) stake by 32% in Q1 2026, selling an estimated $11.4M and leaving 370,069 shares worth $23.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2407.

UBS Group first reported a position in LIVN in Q4 2015 and has held it in 42 quarters since. The position peaked at $36.9M in Q4 2024. 290 funds tracked by Wall St. Rank hold LIVN as of Q1 2026.

  • UBS Group held 370,069 shares of LivaNova worth $23.5M as of Q1 2026.
  • UBS Group sold 177,485 LivaNova shares in Q1 2026, an estimated $11.4M.
  • LivaNova made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2407 holding.
  • UBS Group first reported a position in LivaNova in Q4 2015 and has held it in 42 quarters since.
  • UBS Group's LivaNova position peaked at $36.9M in Q4 2024.
  • 290 funds tracked by Wall St. Rank held LivaNova as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.